Doctors Lluís Espinosa, Jenniffer Linares, and Clara Montagut lead the selected projects. Dr. Sònia Servitja participates in a study led by the IRB.
On February 24, the Association Against Cancer in Barcelona awarded 49 research grants, three of which were for projects led by researchers from the Hospital del Mar Research Institute. In total, nearly 13 million euros have been allocated to boost cancer research in Barcelona.
In the category of general project grants, Dr. Lluís Espinosa, coordinator of the Research Group on Molecular Mechanisms of Cancer and Stemness, received 292,200 euros to investigate how colon and rectal cancer cells resist treatments by acquiring characteristics similar to embryonic cells.
Dr. Jennifer Linares, a researcher from the Colorectal Cancer Precision Medicine Research Group, received one of the Semilla AECC 2024 grants to study treatment resistance in colon cancer, focusing on understanding how the tumor environment affects the efficacy of therapies. She will receive 20,000 euros.
And Dr. Clara Montagut, coordinator of the Colorectal Cancer Precision Medicine Research Group, will receive a TRANSCAN 3-JTC 2023 grant, worth 31,250 euros, for the international project SAGITTARIUS, which aims to identify the genetic causes leading to metastasis in order to improve treatments for colon and rectal cancer.
Dr. Sònia Servitja also takes part in the MetEND project, led by Dr. Roger Gomis of the Institute of Biomedical Research of Barcelona (IRB). With funding of 1.2 million euros, the project aims to identify the signals that favor the growth of bone metastases in breast cancer in order to find ways to block this process.
Image: Lluís Espinosa
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Proceeds to support clinical development of lead first-in-class progra...
